Neuroprotective Effects of Xenon Treatment in Patients with Cerebral Infarction

PHASE3CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

January 1, 2022

Primary Completion Date

January 15, 2024

Study Completion Date

January 15, 2024

Conditions
Ischemic Stroke
Interventions
DRUG

Xenon

"Xenon is injected into the body by inhalation in the form of xenon-oxygen mixtures, in which the concentration of xenon is 30%, and oxygen is 30%.~Xenon inhalation is carried out for 30 min daily for 3 days."

DRUG

Oxygen 30 %

"Oxygen-air mixture is injected into the body by inhalation. The oxygen concentration is 30%.~Inhalation of oxygen-air mixture is carried out for 30 min daily for 3 days"

Trial Locations (1)

141534

V.A. Negovsky Research Institute of General Reanimatology, Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology, Moscow

All Listed Sponsors
lead

Negovsky Reanimatology Research Institute

OTHER_GOV

NCT05335109 - Neuroprotective Effects of Xenon Treatment in Patients with Cerebral Infarction | Biotech Hunter | Biotech Hunter